Knoll Capital Management’s Champions Oncology CSBR Stock Holding History

Knoll Capital Management’s Portfolio CSBR Stock Details CSBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-111,111	Closed	-$184K	–	18
2016 Q3	$184K	Hold	111,111	–	–	0.32%	18
2016 Q2	$239K	Hold	111,111	–	–	0.08%	19
2016 Q1	$405K	Hold	111,111	–	–	0.16%	18
2015 Q4	$397K	Buy	+111,111	New	+$478K	0.15%	18

Other funds holding CSBR

BPI

Battery Partners IX Boston, Massachusetts $22.4M AUM 27.71% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

SKK

Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

SSB

Sandy Spring Bank Olney, Maryland $2.38B AUM 8.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Knoll Capital Management's CSBR Position: Q4 2016 in Review

Knoll Capital Management sold out of Champions Oncology (CSBR) in Q4 2016, closing a stake of 111,111 shares — an estimated $184K sold.

Knoll Capital Management first reported a position in CSBR in Q4 2015 and held it in 4 quarters. The position peaked at $405K in Q1 2016. 11 funds tracked by Wall St. Rank hold CSBR as of Q4 2016.

Knoll Capital Management reported no remaining Champions Oncology position as of Q4 2016 after selling out during the quarter.
Knoll Capital Management sold 111,111 Champions Oncology shares in Q4 2016, an estimated $184K.
Knoll Capital Management first reported a position in Champions Oncology in Q4 2015 and held it in 4 quarters.
Knoll Capital Management's Champions Oncology position peaked at $405K in Q1 2016.
11 funds tracked by Wall St. Rank held Champions Oncology as of Q4 2016.

Based on Knoll Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.